Debut

BeautyMatter's Carla Seipp spoke to Joshua Britton about how Debut is addressing FDA regulations in order to bring its new bio-carmine to market. "Our bio-carmine is the exact same molecule as natural carmine, minus the questionable environmental and ethical practices that have only survived this long because there has been no scientific breakthrough - until now," said Britton. Debut's innovation, four years in the making, was unlocked by a team of ten scientists. "Breakthrough innovation such as our biomanufactured carmine will clearly necessitate an update of FDA statutes. The industry has waited long enough for innovation such as this," he said. #biotechnology #biotechbeauty #carmine #futureofbeauty https://lnkd.in/e_RxHd_r

Thank you,?BeautyMatter?and?Sophie Pitt, for covering the launch of?Debut’s AI-powered ingredient discovery platform, BeautyORB?, that will fuel biotech innovation for all beauty brands globally. “With our advanced AI platform and understanding of skin biology, we can rapidly create brand new ingredients through computational compound prediction,” said Debut’s Founder and CEO,?Joshua Britton. “All this can be done at the click of a button, cutting out years from the innovation cycle and accessing ingredients no one has seen before”.?Debut's new partnership with contract manufacturer?kdc/one, in tandem with Debut’s custom formulation business?BiotechXBeautyLabs?, will enable brands of all sizes to harness the power of biotech. #biotechbeauty #biotech #beautyindustry #futureofbeauty https://lnkd.in/e4dZ-nyu

A big thank you to Fast Company and Adele Peters for covering the news of Debut's breakthrough in carmine bioproduction and unveiling of the first-ever molecular replica of the vibrant red pigment. This is a big launch for the beauty industry and soon-to-be for food and beverages! Read the story here: https://lnkd.in/eqzeWTEk

Joshua Britton?spoke to?Formes de Luxe's Stéphanie Gendron about Debut’s newly launched AI ingredient discovery platform,?BeautyORB?, and its ability to screen a potentially limitless quantity of ingredients to uncover the next generation of hero ingredients. Debut's AI ingredient discovery capabilities, which are accessible via BiotechXBeautyLabs?, discover new and improved cellular pathways for enhanced clinical claims, bringing true innovation and differentiation to brands. https://lnkd.in/dspxP8WR

Debut and BiotechXBeautyLabs will be at MULA for the next two days (February 12 & 13). Come visit us at our booth (E25) and discover our biotech beauty samples! We are so looking forward to it! #MakeUpinLA #MULA #biotechbeauty

Happy LSEC (line-smoothing eye cream) Launch Day! Our Debut team wore our DEINDE sweatshirts to celebrate the launch of DEINDE's Line-Smoothing Eye Cream today! For more information on our new product, visit https://www.deinde.com/ #biotech #beauty #Debut #DEINDE

Join Debut Founder & CEO?Joshua Britton?at?MakeUp in LA’s biotech beauty conference session on February 12 alongside esteemed panelists?Adam R. Jones, Vice President of Business Development, L'Oréal;?David Pina Executive Director, Innovation & Creative,?Element Group USA;?Shirley BILLOT, Founder & CEO,?Kadalys; and?Katarina Tornqvist, Founder,?Sirkka Labs.?Learn how biotech is revolutionizing beauty with unparalleled performance. Looking forward to seeing you there! Session: “Biotech Beauty: Unlocking Endless Formulation & Packaging Innovations” Date: Wednesday February 12 Time: 12:30pm Where: LA Convention Center MakeUp in

L'Oréal-backed biotech firm Debut has released an artificial intelligence (AI)-powered ingredient discovery platform aimed at the beauty industry. BeautyORB works to discover novel ingredients and support “best-in-class claims” for brands. It achieves this by screening an estimated 50 billion molecules for their ability to turn on cellular pathways within the skin. Click the link below to read the full article. Words: Alessandro Carrara

Thank you, Global Cosmetic Industry, for covering the news of Debut's AI ingredient discovery engine, BeautyORB?, and collection of dermatology-focused biotech ingredients, DermCeuticalPRO?, available via BiotechXBeautyLabs?. BeautyORB? enables us to go from consumer insights to novel, peak-performing ingredients and clinically-backed formulations in record time, 12-18 months. https://lnkd.in/eVwqk5_7

I am so excited to reveal several major milestones at Debut today. First, we are releasing our AI/ML Ingredient Discovery engine, BeautyORB?, that has been leveraged to create our new line of dermatology-focused biotech ingredients, the DermCeuticalPRO? Collection. This discovery engine allows us to go from consumer insights to novel, higher-performing ingredients and clinically-backed formulations in 12-18 months (available via BiotechXBeautyLabs?). We will now release two higher performing ingredients a year to our community. Using an in-house proprietary data set containing 60M+ data points (and growing quickly), we now screen upwards of 50BN molecules for novel and higher-performing claims and – spoiler alert – new pathways. Biotech is quickly moving away from biomanufacturing existing ingredients. For companies to win, they need to harness novel, higher-performing ingredients, many of which have never been seen before or exist in trace amounts in nature. Second, our newly formed partnership with kdc/one is vital to the mission of biotech and beauty. Often, exciting developments in biotech have difficulty reaching global supply chains and delivering real impact. This partnership combines best-in-class biotech innovation with the power of kdc/one and their global beauty customers to ensure biotech reaches all. It truly is the perfect partnership and provides much needed differentiation in beauty contract manufacturing through product innovation. Debut will use its expertise in ingredient discovery, biomanufacturing, formulations and clinical testing of products, and KDC/one will activate its best-in-class product manufacturing capabilities to bring biotech to hundreds of global brands. The vision of Sandra Wisniewski and Jamie Plaza Bennett has clearly demonstrated why they are the right partners for Debut. These two step changes go together as we turn our focus to democratizing biotech for all consumers. This is going to be a game-changing year.